Amgen
Igor Rybkin, MD PhD, is a Clinical Research Medical Director at Amgen since November 2021. Prior to this role, Rybkin served as the Vice Chair of the Molecular Tumor Board at the Henry Ford Cancer Institute from November 2017 to November 2021 and was a Clinical Assistant Professor at Wayne State University School of Medicine from March 2017 to November 2021. Rybkin also held the position of Senior Staff Physician at Henry Ford Health System from July 2012 to November 2021. Rybkin obtained a Doctor of Medicine (M.D.) from Orenburg State Medical Academy and a Doctor of Philosophy (Ph.D.) in Genes & Development from UT Southwestern Medical Center at Dallas, as well as education from the University of Michigan.
This person is not in any offices
Amgen
280 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.